within Pharmacolibrary.Drugs.ATC.C;

model C07AA14
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.0011666666666666668,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.18,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.013333333333333334,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C07AA14</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Mepindolol is a non-selective beta-adrenergic antagonist (beta-blocker) that was previously used for the treatment of hypertension and some cardiac arrhythmias. Its clinical use has declined and it is not commonly approved or available for therapy today.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical healthy adult; no direct published clinical PK data could be identified.</p><h4>References</h4><ol><li><p>Krause, W, &amp; Kühne, G (1983). Pharmacokinetics of mepindolol sulfate in the rat, dog, and rhesus monkey. Studies on species differences. <i>Drug metabolism and disposition: the biological fate of chemicals</i> 11(2) 91–96. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6133729/\">https://pubmed.ncbi.nlm.nih.gov/6133729</a></p></li><li><p>Krause, W, et al., &amp; Fischer, HC (1984). Pharmacokinetics of mepindolol in patients with chronic renal failure. <i>European journal of clinical pharmacology</i> 27(4) 429–433. DOI:<a href=\"https://doi.org/10.1007/BF00549590\">10.1007/BF00549590</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6519149/\">https://pubmed.ncbi.nlm.nih.gov/6519149</a></p></li><li><p>de Mey, C, et al., &amp; Osterwald, H (1989). Transdermal delivery of mepindolol and propranolol in normal man. 2nd communication: pharmacokinetic and neuro-endocrine aspects. <i>Arzneimittel-Forschung</i> 39(11A) 1508–1512. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2576201/\">https://pubmed.ncbi.nlm.nih.gov/2576201</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C07AA14;
